BBIO Operating Cash Flow (Statement)
Bridgebio Pharma Inc · Operating Cash Flow (Statement)
BBIO Operating Cash Flow (Statement)
Latest reported-$434.37Mperiod ending
BBIO Cash from Operations (-$40.49M → -$434.37M)
Annual operating cash flow (statement)
High-resolution chart · PNG
BBIO operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -445,910,000 | |
| -520,726,000 | |
| -527,720,000 | |
| -419,494,000 | |
| -497,934,000 | |
| -399,714,000 | |
| -253,587,000 | |
| -136,643,000 | |
| -40,488,000 |